FDA issues warning about ADHD drugs
22 February, 2007 by Kate McDonaldThe US FDA has told manufacturers of ADHD drugs to warn patients of potential adverse effects.
Xenograph models to help children resist cancer
20 February, 2007 by Fiona WylieResistance to glucocorticoid therapy remains an important factor in the battle to achieve high cure rates in childhood leukaemia. Researcher Richard Lock has helped develop a xenograph model to identify drug resistance mechanisms.
Preventing metastasis with molecular decoys
16 February, 2007 by Graeme O'NeillAngiogenesis inhibition is not enough - blocking the formation of new lymphatic vessels is vital to preventing secondary tumours.
Angiogenesis and untying tumours
15 February, 2007 by Fiona WylieRuth Ganss is an immunologist by trade who has become intrigued by the nature of tumour development.
Migraines and a shunt in the heart
14 February, 2007 by Kate McDonaldIs there a link between a common heart defect and a high incidence of migraine? International experience seems to suggest so.
Steps on the road to the Holy Grail
02 February, 2007 by Fiona WylieThe publication of the molecular structure of the insulin receptor last September, led by Australia's Colin Ward, was a milestone in the life sciences. Fiona Wylie profiles the man behind the receptor.
CMRI looks at p53 and Rett Syndrome
01 February, 2007 by Kate McDonaldThe Children's Medical Research Institute in Sydney has set up a new unit to look at the p53 tumour suppressor gene, and one of its young scientists has received further funding for his research into Rett Syndrome.
Insulin xenotransplantation trial gets go ahead
01 February, 2007 by Kate McDonaldAustralian biotech Living Cell Technologies (LCT) has been given the green light to start a xenotransplantation trial in diabetic patients in Russia.
Tat and a potential off-switch for HIV
18 January, 2007 by Staff WritersA Princeton University study suggests it may be possible to deactivate viruses such as HIV indefinitely with the flick of a genetic switch.
Lung cancer vaccine trial begins recruitment
16 January, 2007 by Kate McDonaldAustralian hospitals will be involved in a global Phase III clinical trial of a potential cancer vaccine.
Prana raises cash for next-phase Alzheimer's trials
27 November, 2006 by ABN StaffPrana Biotechnology has raised $7.8 million in cash to add to its fund for a Phase IIa trial in human patients of its PBT2 compound for Alzheimer's disease.
The body, the brain and Huntington's disease
16 November, 2006 by ABN StaffScientists at Melbourne's Howard Florey Institute have shown that physical exercise alone can delay onset of memory loss in Huntington's disease (HD), but a combination of mental and physical exercise is more beneficial in delaying the fatal genetic disease's symptoms.
From laboratory to bedside
15 November, 2006 by Fiona Wylie"It is not that stem cell transplantation doesn't work, it is just that we need more work to figure it out." With this kind of simple optimism, and a little green jasmine tea, Professor Brent Reynolds chatted with Fiona Wylie about life, coincidence and the use of neural stem cells to treat spinal cord injury.
Spinal cord repair - just add water
15 November, 2006 by Fiona WylieThe Australian Stem Cell Centre is studying an alternative approach to treating spinal cord damage using acellular dermal matrix processing. Fiona Wylie spoke to the ASCC's Kathy Traienedes.
Peter Mac joins Affymetrix translational medicine program
15 November, 2006 by Kate McDonaldMelbourne's Peter MacCallum Cancer Centre has entered into a five-year collaboration with Affymetrix to use the company's GeneChip microarray technology for translational research projects. Kate McDonald reports.
